TB treatment gets a precision boost: study tests custom drug dosing

NCT ID NCT06585358

Recruiting now Knowledge-focused Sponsor: Karolinska Institutet Source: ClinicalTrials.gov ↗

First seen Nov 21, 2025 · Last updated May 01, 2026 · Updated 18 times

Summary

This study looks at whether using a computer model to personalize the dose of tuberculosis (TB) drugs can help patients get the right amount of medicine. About 30 adults with pulmonary TB will have their drug levels measured, and doctors will use that information to adjust doses quickly. The goal is to see if this approach helps more patients reach the ideal drug levels early in treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TUBERCULOSIS, PULMONARY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Karolinska University Hospital
RECRUITING

Stockholm, 17177, Sweden

Contact Email: •••••@•••••

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Linköping University Hospital
RECRUITING

Linköping, Sweden

Contact Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

TUBERCULOSIS, PULMONARY